Rheumatoid arthritis: What have we learned about the causing factors?

Pakistan Journal of Pharmaceutical Sciences

Volumn 29, Issue 2, 2016, Pages 629-645

  Jalil, Syed Fazal ^a   Arshad, Maria ^b   Bhatti, Attya ^b   Ahmad, Jamil ^b   Akbar, Fazal ^c   Ali, Shahid ^c   John, Peter ^b  

^a ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^b NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

^c University of Swat   (Pakistan)

Author keywords

Environmental factors; Etiology; Genetic factors; Rheumatoid arthritis

Indexed keywords

BONE EROSION; DISABILITY; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; HEREDITY; HUMAN; LIFESTYLE; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SOCIOECONOMICS; ANIMAL; ARTHRITIS, RHEUMATOID; DISEASE MODEL; ENVIRONMENT; GENETIC PREDISPOSITION; GENETICS; PROGNOSIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84963820894     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (193)

1. Aaseth J, Haugen M and Forre O (1998). Rheumatoid arthritis and metal compounds-perspectives on the role of oxygen radical detoxification. Analyst., 123(1): 3-6.
2. Adam O, Beringer C and Kless T et al (2003). Antiinflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int., 23(1): 27-36.
3. Alamanos Y, Voulgari PV and Drosos AA (2006). Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review. Semin. Arthritis Rheum, 36: 182-188.
4. Amos CI, Chen WV, Lee A, Li W, Kern M, Lundsten R, Batliwalla F, Wener M, Remmers E, Kastner DA, Criswell LA, Seldin MF and Gregersen PK (2006). High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun., 7: 277-286.
5. Arndt U, Rittmeister M and Möller B (2003). Drug therapy of rheumatoid arthritis. Orthopade., 32(12): 1095-1103.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS and Healey LA et al (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 31: 315-324.
7. Asimit J and Zeggini E (2011). Testing for rare variant associations in complex diseases. Genome. Med., 3: 24- 26.
8. Bang SY, Lee KH, Cho SK, Lee HS, Lee KW and Bae SC (2010). Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anticyclic citrullinated peptide antibody status. Arthritis Rheum, 62(2): 369-377.
9. Baroja ML, Darlington PJ, Carreno BM and Madrenas J (2000). Inhibition of T cell activation by CTLA-4: Truths and red herrings. Mod. Asp. Immunobiol., 1: 169- 173.
10. Baroja ML, Vijayakrishnan L, Bettelli E, Darlington PJ and Chau TA et al (2002). Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J. Immunol., 168: 5070-5078.
11. Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J and Gibbons L et al (2008). Re-evaluation of putative rheumatoid arthritis susceptibility genes in the postgenome- wide association study era and hypothesis of a key pathway underlying susceptibility. Hum. Mol. Genet, 17: 2274-2279.
12. Bax M, Heemst JV, Huizinga TWJ and Toes REM (2011). Genetics of rheumatoid arthritis: What have we learned. Immunogenetics, 63: 459-466.
13. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP and Alexander HC et al (2004). A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet, 75(2): 330-337.
14. Bengtsson C, Nordmark B, Klareskog L, Lundberg I and Alfredsson L (2005). Socio-economic status and the risk of developing rheumatoid arthritis: Results from the Swedish EIRA study. Ann. Rheum. Dis., 64: 1588- 1594.
15. Berkanovic E, Oster P, Wong WK, Bulpitt K, Clements P, Sterz M and Paulus H (1996). The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis. Arthritis Care. Res., 9(6): 257- 262.
16. Bettelli E, Oukka M and Kuchroo VK (2007) T (H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol., 8: 345-350.
17. Bottini N, Musumeci L and Alonso A et al (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet, 36: 337- 338.
18. Bowes J, Ho P, Flynn E, Ali F, Marzo-Ortega H, Coates LC and Warren RB et al (2012). Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritiscohort. Ann. Rheum. Dis., 71(8): 1350-1354.
19. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M and Suzan M et al (1987). A new member of the immunoglobulin superfamily-CTLA-4. Nature, 328: 267-270.
20. Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R and Laffon A (2002). The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford)., 41: 88-95.
21. Chan KW, Felson DT, Yood RA and Walker AM (1993). Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum, 36: 1691-1696.
22. Cloutier JF and Veillette A (1999). Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med., 189: 111-121.
23. Cloutier JF and Veillette A (1999). Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med., 189(1): 111-121.
24. Cohen S, Dadi H, Shaoul E, Sharfe N and Roifman CM (1999). Cloning and characterization of a lymphoidspecific, inducible human protein tyrosine phosphatase. Lyp. Blood, 93: 2013-2024.
25. Costenbader KH, Chang SC, Laden F, Puett R and Karlson EW (2008). Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch. Intern. Med., 168: 1664-1670.
26. Costenbader KH, Feskanich D, Mandl LA and Karlson EW (2006). Smoking intensity, duration and cessation, and the risk of rheumatoid arthritis in women. Am. J. Med., 119: 5031-5039.
27. Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V and Robson S et al (2010). Wellcome trust case control consortium, Genome-wide association study of CNVs in16, 000 cases of eight common diseases and 3, 000 shared controls. Nature, 464: 713-720.
28. Criswell LA and Katz PP (1994). Relationship of education level to treatment received for rheumatoid arthritis. J. Rheumatol., 21(11): 2026-2033.
29. Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS and Burma M et al (2002). Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: Results from the Iowa Women's Health Study. Am. J. Med., 15: 465-471.
30. Cuzzocrea S (2011). Characterization of a novel and spontaneous mouse model of infl ammatory arthritis. Arthritis Research & Therapy, 13: 126.
31. Dariavach P, Mattei MG, Golstein P and Lefranc MP (1988). Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol., 18: 1901-1905.
32. De Matteis MA and Luini A (2011). Mendelian disorders of membrane trafficking. New England Journal of Medicine, 365(10): 927-938.
33. Deichmann K, Heinzmann A, Bruggenolte E, Forster J and Kuehr J (1996). An Mse I RFLP in the human CTLA4 promotor. Biochem. Biophys. Res. Commun., 225: 817-818.
34. Depienne C, Stevanin G, Brice A and Durr A (2007). Hereditary Spastic Paraplegia: An Update. Current Opinions in Neurology, 20(6): 674-680.
35. deVries R (2011). Genetics of rheumatoid arthritis: Time for a change. Curr. Opin. Rheumatol., 23(3): 227-232.
36. Di-Giuseppe D, Alfredsson L, Bottai M, Askling J and Wolk A (2012). Long term alcohol intake and risk of rheumatoid arthritis in women: A population based cohort study. BMJ., 345: E4230.
37. Donner H, Rau H, Walfish PG, Braun J and Siegmund T et al (1997). CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab., 82: 143-146.
38. Doran MF, Crowson CS, O'Fallon WM and Gabriel SE (2004). The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: A population based study. J. Rheumatol., 31(2): 207- 213.
39. Doran MF, Pond GR and Crowson CS et al (2002). Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum, 46: 625-631.
40. du Montcel ST, Michou L and Petit-Teixeira E et al (2005). New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum, 52: 1063-1068.
41. Emery P, Salmon M (1995) Early rheumatoid arthritis: Time to aim for remission? Ann. Rheum Dis., 54: 944- 947.
42. Eyre S, Bowes J, Diogo D, Lee A, Barton A and Martin P et al (2012). High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet, 44(12): 1336-1340.
43. Fan J, Edsen-Moore MR, Turner LE, Cook RT, Legge KL and Waldschmidt TJ et al (2011). Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation. Alcohol. Clin. Exp. Res., 35: 47-59.
44. Fiorillo E, Orru V, Stanford SM, Liu Y, Salek M and Rapini N et al (2010). Autoimmune associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J. Biol. Chem., 285(34): 26506-26518.
45. Fitzpatrick R, Newman S, Archer R and Shipley M (1991). Social support, disability and depression: A longitudinal study of rheumatoid arthritis. Soc. Sci. Med., 33(5): 605-611.
46. Fleming A, Crown JM and Corbett M (1976). Early rheumatoid disease. I. Onset. Ann. Rheum Dis., 35(4): 357-360.
47. Freeman GJ, Borriello F, Hodes RJ, Reiser H and Gribben JG et al (1993a). Murine B7-2, an alternative CTLA4 counter-receptor that costimulates Tcell proliferation and interleukin2 production. J. Exp. Med., 178: 2185- 2192.
48. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW and Restivo VA Jr et al (1993b). Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science, 262: 909-911.
49. Frucht DM, Aringer M, Galon J, Danning C, Brown M and Fan S et al (2000). Stat 4 is expressed in activated peripheral blood monocytes, dendritic cells and macrophages at sites of Th1-mediated inflammation. J. Immunol., 164: 4659.
50. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P and Felson D et al (2010). The 2010 American college of rheumatology/european league against rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann. Rheum. Dis., 69(9): 1589-1595.
51. Furner SE, Hootman JM, Helmick CG, Bolen J and Zack MM (2011). Health-related quality of life of US adults with arthritis: Analysis of data from the behavioral risk factor surveillance system, 2003, 2005 and 2007. Arthritis. Care Res. (Hoboken), 63(6): 788-799.
52. Geraghty D, Inoko H, Beck S, Trowsdale J, Campbell D and Rowen L et al (1999). Complete sequence and gene map of a human major his to compatibility complex. The MHC Sequencing Consortium. Nature, 401(6756): 921-923.
53. Gjörloff-Wingren A, Saxena M, Williams S, Hammi D and Mustelin T (1999). Characterization of TCRinduced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol., 29(12): 3845-3854.
54. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G and Criswell LA (2004). Impact of shared epitope genotype and ethnicity on erosive disease: A metaanalysis of 3, 240 rheumatoid arthritis patients. Arthritis Rheum, 50: 400-412.
55. Gregersen PK (2005). Gaining insight into PTPN22 and autoimmunity. Nat. Genet, 37(12): 1300-1302.
56. Gregersen PK, Silver J and Winchester RJ (1987). The shared epitope hypothesis. An approach tounderstanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum, 30: 1205- 1213.
57. Guillemin F, Briancon S and Klein JM et al (1994). Low incidence of rheumatoid arthritis in France. Scand J. Rheumatol., 23: 264-268.
58. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P and LeBihan E et al (2005). Prevalence of rheumatoid arthritis in France: 2001. Ann. Rheum. Dis. 64: 1427-1430.
59. Hamlin PJ, Jones PF, Leek JP, Bransfield K, Lench NJ, Aldersley MA, Howdle PD, Markham AF and Robinson PA (1998). Assignment of GALGT encoding beta-1, 4N-acetylgalactosaminyl-transferase (GalNAc- T) and KIF5A encoding neuronal kinesin (D12S1889) to human chromosome band 12q13 by assignment to ICI YAC 26EG10 and in situ hybridization. Cytogenet. Cell Genet, 82: 267-268.
60. Harney SM, Vilarĩno-Guell C and Adamopoulos IE et al (2008). Fine mapping of the MHC class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology (Oxford), 47: 1761-1767.
61. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF and Golstein P (1991). CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. J. Immunol., 147: 1037-1044.
62. Hart JE, Laden F, Puett RC, Costenbader KH and Karlson EW (2009). Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect, 117(7): 1065-1069.
63. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L and Chan AC (2004). PEST domain-enriched tyrosine phosphatase (PEP) regulation of effect or/memory T cells. Science, 303: 685-689.
64. Hawley DJ and Wolfe F (1988). Anxiety and depression in patients with rheumatoid arthritis: A prospective study of 400 patients. J. Rheumatol., 15(6): 932-941.
65. Hazes JM, Dijkmans BA, Vandenbroucke JP, de Vries RR and Cats A (1990). Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann. Rheum Dis., 49: 980-982.
66. Heliovaara M, Aho K, Aromaa A, Knekt P and Reunanen A (1993). Smoking and risk of rheumatoid arthritis. J. Rheumatol., 20: 1830-1835.
67. Hill RJ, Zozulya S, Lu YL, Ward K, Gishizky M and Jallal B (2002). The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp. Hematol., 30(3): 237-244.
68. Imboden JB (2009). The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol., 4: 417-434.
69. Jalil SF, Bhatti A, Demirci FY, Wang X, Ahmed I, Ahmed M, Barmada MM, Malik JM, John P and Kamboh MI (2013). Replication of european rheumatoid arthritis loci in a Pakistani population. J. Rheumatol., 40(4): 401-407.
70. Jonsson IM, Verdrengh M, Brisslert M, Lindblad S, Bokarewa M and Islander U et al (2007). Ethanol prevents development of destructive arthritis. Proc. Nat. Acad. Sci. USA, 104: 258-263.
71. Kaipiainen-Seppanen O and Aho K (2000). Incidence of chronic inflammatory joint diseases in Finland in 1995. J. Rheumatol., 27: 94-100.
72. Kaipiainen-Seppanen O and Kautiainen H (2006). Declining trend in the incidence of rheumatoid factor positive rheumatoid arthritis in Finland 1980-2000. J. Rheumatol., 33(11): 2132-2138.
73. Kallberg H, Jacobsen S, Bengtsson C, Pedersen M, Padyukov L and Garred P et al (2009). Alcohol consumption is associated with decreased risk of rheumatoid arthritis: Results from two Scandinavian case-control studies. Ann. Rheum Dis., 68: 222-227.
74. Karlson E, Lee I, Cook N, Manson J, Buring J and Hennekens C (1999). A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42: 910- 917.
75. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, Devivo I and Costenbader KH (2010). Geneenvironment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident RA. Ann. Rheum Dis., 69(1): 54-60.
76. Kerr GS, Sabahi I, Richards JS, Caplan L, Cannon GW and Reimold A et al (2010). Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J. Rheumatol., 38(1): 53-59.
77. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C and Grunewald J et al (2006). A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum, 54: 38-46.
78. Knevel R, Knevel R, Gröndal G, Huizinga TW, Visser AW, Jónsson H, Víkingsson A, Geirsson AJ, Steinsson K and vander Helm-van Mil AH (2012). Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: A population-based study. Ann. Rheum Dis., 71: 707-709.
79. Kobayashi S, Ikari K, Kaneko H, Kochi Y, Yamamoto K, Shimane K and Nakamura Y et al (2008). Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum, 58: 1940-1946.
80. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C and Takahashi A et al (2010). A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet, 42: 515-519.
81. Kristiansen OP, Larsen ZM and Pociot F (2000). CTLA-4 in autoimmune diseases a general susceptibility gene to autoimmunity? Genes Immun., 1: 170-184.
82. Lai HM and Chen CJ (2008). Biologics in the treatment of rheumatoid arthritis: Recent advances. Formosan Journal of Rheumatology, 22: 12-24.
83. Lee DM and Weinblatt ME (2001). Rheumatoid arthritis. Lancet, 358: 903-911.
84. Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC and Gregersen PK (2007). Association of STAT 4 with rheumatoid arthritis in the Korean population. Mol. Med., 13: 455-460.
85. Lee KM, Chuang E, Griffin M, Khattri R and Hong DK et al (1998). Molecular basis of Tcell inactivation by CTLA-4. Science, 282: 2263-2266.
86. Lee YH, Woo JH, Choi SJ, Ji JD and Song GG (2010). Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: A meta-analysis. Rheumatol. Int., 30(5): 661-666.
87. Lee YH, Bae SC, Choi SJ, Ji JD and Song GG (2012). Association between the CTLA4 +49A/G polymorphism and susceptibility to rheumatoid arthritis: A meta-analysis. Mol. Biol. Rep., 39: 5599- 5605.
88. Leonard WL and O'Shea JJ (1998). JAKS and STATs: Biological implications. Annu. Rev. Immunol., 16: 293.
89. Li S and Micheletti R (2011). Role of diet in rheumatic disease. Rheum. Dis. Clin. North Am., 37(1): 119-133.
90. Liang YL, Wu H, Shen X, Li PQ, Yang XQ, Liang L, Tian WH, Zhang LF and Xie XD (2012). Association of STAT4 rs7574865 polymorphism with autoimmune diseases: A meta-analysis. Mol. Biol. Rep., 39(9): 8873- 8882.
91. Lin CH, Cho CL and Tsai WC et al (2006). Inhibitors of kB-like gene polymorphisms in rheumatoid arthritis. Immunol. Lett., 105: 193-197.
92. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D and Saxne T (2005). Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann. Rheum Dis., 64: 196-201.
93. Lindsten T, Lee KP, Harris ES, Petryniak B and Craighead N et al (1993). Characterization of CTLA-4 structure and expression on human T cells. J. Immunol., 151: 3489-3499.
94. Ling V, Wu PW, Finnerty HF, Sharpe AH, Gray GS and Collins M (1999). Complete sequence determination of the mouse and human CTLA4 gene loci: Cross-species DNA sequence similarity beyond exon borders. Genomics, 60: 341-355.
95. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK and Ledbetter JA (1991). CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med., 174: 561-569.
96. Linsley PS, Clark EA and Ledbetter JA (1990). T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci., USA 87: 5031-5035.
97. Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA and Peach R (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity, 1: 793-801.
98. Linsley PS, Nadler SG, Bajorath J, Peach R and Leung HT et al (1995). Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules. J. Biol. Chem., 270: 15417-15424.
99. Lorant V, Deliege D, Eaton W, Robert A, Philippot P and Ansseau M (2003). Socioeconomic inequalities in depression: A meta-analysis. Am. J. Epidemiol., 157(2): 98-112.
100. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K and Silman AJ (2000). Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum, 43: 30-37.
101. Mackenbach JP, Kunst AE, Cavelaars AE, Groenhof F and Geurts JJ (1997). Socio- economic inequalities in morbidity and mortality in western Europe. The EU Working Group on Socioeconomic Inequalities in Health. Lancet, 349(9066): 1655-1659.
102. Magistrelli G, Jeannin P, Herbault N, Benoit DC and Gauchat JF et al (1999). A soluble form of CTLA-4 generated by alternative splicing is expressed by non stimulated human T cells. Eur. J. Immunol., 29: 3596- 3602.
103. Majithia V and Geraci SA (2007). Rheumatoid arthritis: Diagnosis and management. Am. J. Med., 120: 936- 939.
104. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ and Eklund A et al (2008). Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann. Rheum Dis., 67(10): 1488-1492.
105. Mandrekar P, Catalano D, Dolganiuc A, Kodys K and Szabo G (2004). Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production. J. Immunol., 173: 3398-3407.
106. Marinou I, Maxwell JR and Wilson AG (2010). Genetic influences modulating the radiological severity of rheumatoid arthritis. Ann. Rheum Dis., 69: 476-482.
107. Martinez A, Varade J, Marquez A, Cenit MC, Espino L, Perdigones N and Santiago JL et al (2008). Association of the STAT 4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum, 58: 2598-2602.
108. Mathieu C, Van Etten E and Gysemans C et al (2001). In vito and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner Res., 16: 2057-2065.
109. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS and Kaplan MH (2007). Stat 3 and Stat 4 direct development of IL-17-secreting Th cells. J. Immunol., 178: 4901-4907.
110. Mattey DL, Hassell AB, Dawes PT, Ollier WE and Hajeer A (1999). Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: Influence on disease outcome. Arthritis Rheum, 42: 2698-2704.
111. Maxwell JR, Gowers IR, Moore DJ and Wilson AG (2010). Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford), 49: 2140-2146.
112. McCabe CJ, Akehurst RL, Kirsch J, Whitfield M, Backhouse M, Woolf AD, Scott DL, Emery P, Haslock I (1998). Choice of NSAID and management strategy in rheumatoid arthritis and osteoarthritis. The impact on costs and outcomes in the UK. Pharmacoeconomics, 14(2): 191-199.
113. McKellar G, Morrison E and McEntegart A et al (2007). A pilot study of a Mediterranean-diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann. Rheum. Dis., 66(9): 1239-1243.
114. Metzler WJ, Bajorath J, Fenderson W, Shaw SY and Constantine KL et al (1997). Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat. Struct. Biol., 4: 527-531.
115. Mitchell JM, Burkhauser RV and Pincus T (1988). The importance of age education and co-morbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum, 31(3): 348- 357.
116. Morinobu A, Gadina M and Strober W et al (2002). STAT4 serine phosphorylation is critical for IL-12- induced IFN-gamma production but not for cell proliferation. Proc. Natl. Acad. Sci. USA, 99: 12281- 12286.
117. Mu H, Chen JJ, Jiang Y, King MC, Thomson G and Criswell LA (1999). Tumor necrosis factor a micro satellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLADRB1 shared epitope. Arthritis Rheum, 42: 438-442.
118. Murphy KM and Reiner SL (2002). The lineage decisions of helper T cells. Nat. Rev. Immunol., 2: 933.
119. Newton JL, Harney SM, Wordsworth BP and Brown MA (2004). A review of the MHC genetics of rheumatoid arthritis. Genes Immun., 5: 151-157.
120. Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ and Strober W (2002). Activated STAT 4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL- 12R beta 2 chain expression and signaling. J. Immunol., 169: 4388-4398.
121. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B and Giovannini C et al (1996). The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet., 5: 1075-1080.
122. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ and Tector AJ (2000). A native soluble form of CTLA-4. Cell Immunol., 201: 144-153.
123. Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K and Suzuki A et al (2012). Meta analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genetics, 44(5): 511-516.
124. Orozco G, Alizadeh BZ, Delgado-Vega AM, Gonzalez- Gay MA, Balsa A, Pascual-Salcedo D and Fernandez- Gutierrez B et al (2008). Association of STAT 4 with rheumatoid arthritis: A replication study in three European populations. Arthritis Rheum, 58: 1974-1980.
125. Ostrov DA, Shi W, Schwartz JC, Almo SC and Nathenson SG (2000). Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science, 290: 816- 819.
126. Ota M, Katsuyama Y and Kimura A et al (2001). A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics, 71: 263-270.
127. Padyukov L, Silva C, Stolt P, Alfredsson L and Klareskog L (2004). A gene environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum, 50: 3085-3092.
128. Palomino-Morales RJ, Rojas-Villarraga A, Gonzalez CI, Ramirez G, Anaya JM and Martin J (2008). STAT 4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun., 9: 379- 382.
129. Patel S, Farragher T, Berry J, Bunn D, Silman A and Symmons D (2007). Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum, 56(7): 2143-2149.
130. Pattison DJ, Symmons DP and Lunt M et al (2004). Dietary risk factors for the development of inflammatory polyarthritis: Evidence for a role of high level of red meat consumption. Arthritis Rheum, 50: 3804-3812.
131. Pedersen JK, Kjaer NK, Svendsen AJ and Hørslev- Petersen K (2009). Incidence of rheumatoid arthritis from 1995 to 2001: Impact of ascertainment from multiple sources. Rheumatol. Int., 29(4): 411-415.
132. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A and Wohlfahrt J et al (2006). Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res. Ther., 8: R133.
133. Perkins D, Wang Z, Donovan C, He H and Mark D et al (1996). Regulation of CTLA-4 expression during T cell activation. J. Immunol., 156: 4154-4159.
134. Pioli C, Gatta L, Ubaldi V and Doria G (2000). Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J. Immunol., 165: 5530-5536.
135. Pistillo MP, Tazzari PL, Palmisano GL, Pierri I and Bolognesi A et al (2003). CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood, 101: 202-209.
136. Plant D, Flynn E, Mbarek H, Dieude P, Cornelis F and Arlestig L et al (2010). Investigation of potential non- HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann. Rheum Dis., 69(8): 1548-1553.
137. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C and Burtt NP et al (2008). Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet, 40(10): 1216-1223.
138. Rayman MP and Callaghan A (2006). Nutrition and arthritis: Blackwell Publishing Ltd. Oxford, UK, p. 264.
139. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW and de Bakker PI et al (2007). STAT 4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med., 357: 977-986.
140. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C and Concannon P et al (2007). Genetic variation in PTPN 22 corresponds to altered function of T and B lymphocytes. J. Immunol., 179: 4704-4710.
141. Ruddy S, Harris ED, Sledge CB and Kelley WN (2005). Clinical features of rheumatoid arthritis. In: Eds. Kelley's Textbook of rheumatology, 7th edn, WB Saunders, Philadelphial, pp.1043-1078.
142. Saraux A, Guedes C, Allain J, Devauchelle V, Valls I and Lamour A et al (1999). Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. J. Rheumatol., 26: 2622-2627.
143. Sato M, Miyazaki T, Nagaya T, Murata Y, Ida N and Maeda K et al (1996). Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemo attractant protein-1 and collagenase expression in cultured human synovial cells. J. Rheumatol., 23(3): 432-438.
144. Savolainen E, Kaipiainen-Seppanen O and Kroger L et al (2003). Total incidence and distribution of inflammatory joint diseases in a defined population: Results from the Kuopio 2000 arthritis survey. J. Rheumatol., 30: 2460-2468.
145. Schneider H, Prasad KV, Shoelson SE and Rudd CE (1995). CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med., 181: 351-355.
146. Seldin MF, Amos CI, Ward R and Gregersen PK (1999). The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum, 42: 1071-1079.
147. Shapira Y, Agmon-Levin N and Shoenfeld Y (2010). Geoepidemiology of autoimmune rheumatic diseases. Nat. Rev. Rheumatol., 6(8): 468-476.
148. Shiratori T, Miyatake S, Ohno H, Nakaseko C and Isono K et al (1997). Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrinassociated adaptor complex AP-2. Immunity., 6: 583-589.
149. Silman AJ and Pearson JE (2002). Epidemiology and genetics of rheumatoid arthritis. Arthritis Res., 4: 265- 272.
150. Silman AJ and Symmons DP (1995). Selection of study population in the development of rheumatic disease criteria: Comment on the article by the American college of rheumatology diagnostic and therapeutic criteria committee. Arthritis Rheum, 38: 722-723.
151. Silman AJ, MacGregor AJ, Thomson W, Holligan S, Carthy D, Farhan A and Ollier WE (1993). Twin concordance rates for rheumatoid arthritis: Results from a nationwide study. Br. J. Rheumatol., 32: 903- 907.
152. Skapenko A, Leipe J, Lipsky PE and Schulze-Koops H (2005). The role of the T cell in autoimmune inflammation. Arthritis Res. Ther., 7(2): S4-S14.
153. Skoldstam L, Hagfors L and Johansson G (2003). An experimental study of a Mediterranean diet intervention for patiets with rheumatoid arthritis. Ann. Rheum Dis., 62(3): 208-214.
154. Smedslund G, Byfuglien M and Olsen S et al (2010). Effectiveness and safety of dietary interventions for rheumatoid arthritis: A systematic review of randomized controlled trials. J. Am. Diet. Assoc., 110(5): 727-735.
155. Smolen JS, Aletaha D, Grisar J, Redlich K, Steiner G and Wagner O (2008). The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: Where are we now? Arthritis Res. Ther., 10(3): 208.
156. Stahl EA and Raychaudhuri S (2012). Evidence for a genetic component to disease severity in RA. Nat. Rev. Rheumatol., 8: 312-313.
157. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S and Thomson BP et al (2010). Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet, 42: 508-514.
158. Stansfeld SA, Head J and Marmot MG (1998). Explaining social class differences in depression and wellbeing. Soc. Psychiatry Psychiatr. Epidemiol., 33(1): 1-9.
159. Steinman L (2007). A brief history of T (H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cellmediated tissue damage. Nat. Med., 13: 139-145.
160. Stolt P, Yahya A, Bengtsson C, Kallberg H, Ronnelid J and Lundberg I et al (2010). Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann. Rheum Dis., 69(6): 1072-1076.
161. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L and Alfredsson L (2003). Quantification of the influence of cigarette smoking on rheumatoid arthritis: Results from a population based case-control study, using incident cases. Ann. Rheum Dis., 62: 835- 841.
162. Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M and Singh-Manoux A (2010). Association of socioeconomic position with health behaviors and mortality. JAMA, 303(12): 1159-1166.
163. Symmons D, Turner G, Webb R, Asten P, Barrett E and Lunt M et al (2002). The prevalence of rheumatoid arthritis in the United Kingdom: New estimates for a new century. Rheumatology (Oxford), 41: 793-800.
164. Symmons DP, Bankhead C, Harrison BJ, Brennan P, Barrett E and Scott DG et al (1997). Blood transfusion, smoking and obesity as risk factors for the development of rheumatoid arthritis: Results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum, 40: 1955-1961.
165. Symmons DP, Barrett EM and Bankhead CR et al (1994). The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br. J. Rheumatol., 33: 735-739.
166. Takahashi T, Tagami T, Yamazaki S, Uede T and Shimizu J et al (2000). Immunologic self tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 192: 303-310.
167. Tamiya G, Shinya M and Imanishi T et al (2005). Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum. Mol. Genet, 14: 2305- 2321.
168. Tłustochowicz W (2006). Rational therapeutic approach in rheumatoid arthritis. Ann. Acad. Med. Stetin., 52(2): 5-10.
169. Tobón GJ, Youinou P and Saraux A (2010) The environment, geo-epidemiology and autoimmune disease: Rheumatoid arthritis. J. Autoimmun., 35(1): 10-14.
170. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V and Bailey R et al (2007). Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet, 39: 857-864.
171. Too CL, Yahya A, Murad S, Dhaliwal JS, Larsson PT, Muhamad NA and Abdullah NA et al (2012). Smoking interacts with HLA-DRB1 shared epitope in the development of anti-citrullinated protein antibodypositive rheumatoid arthritis: Results from the Malaysian epidemiological investigation of rheumatoid arthritis (MyEIRA). Arthritis Res. Ther., 14(2): R89.
172. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423: 506-511.
173. Uhlig T, Hagen K and Kvien T (1999). Current tobacco smoking, formal education and the risk of rheumatoid arthritis. J. Rheumatol., 26: 47-54.
174. van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ and Haanen HC et al (1996). The effectiveness of early treatment with second-line antirheumatic drugs. A randomized, controlled trial. Ann. Intern. Med., 124: 699-707.
175. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE and deVries RR (2004). Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum, 50: 2113-2121.
176. Vang T, Congia M, Macis MD, Musumeci L, Orrú V, Zavattari P, Nika K, Tautz L, Taskén K, Cucca F, Mustelin T and Bottini N (2005). Autoimmuneassociated lymphoid tyrosine phosphatase is a gain-offunction variant. Nat. Genet, 37(12): 1317-1319.
177. Verma S, Alexander CM, Carlson MJ, Tygrett LT and Waldschmidt TJ (2008). B-cell studies in chronic ethanol mice. Methods. Mol. Biol., 447: 295-323.
178. Vessey MP, Villard-Mackintosh L and Yeates D (1987). Oral contraceptives, cigarette smoking and other factors in relation to arthritis. Contraception, 35: 457- 464.
179. Vijayakrishnan L, Slavik JM, Illes Z, Greenwald RJ and Rainbow D et al (2004). An autoimmune diseaseassociated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity, 20: 563-575.
180. Viken MK, Amundsen SS, Kvien TK, Boberg KM and Gilboe IM et al (2005). Association analysis of the 1858C. T polymorphism in the PTPN 22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun., 6: 271-273.
181. Visconti R, Gadina M, Chiariello M, Chen EH, Stancato LF, Gutkind JS and O'Shea JJ (2000). Importance of the MKK6/p38 pathways for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood, 96: 1844.
182. Waldschmidt TJ, Cook RT and Kovacs EJ (2006). Alcohol and inflammation and immune responses: Summary of the 2005 alcohol and immunology research interest Group (AIRIG) meeting. Alcohol, 38: 121-125.
183. Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V and Beroukas D et al (2006). Expression of Jak3, STAT 1, STAT 4 and STAT 6 in inflammatory arthritis: Unique Jak 3 and STAT 4 expression in dendritic cells in seropositive rheumatoid arthritis. Ann. Rheum Dis., 65: 149-156.
184. Walker JG, Ahern MJ, Coleman M, Weedon H, Papangelis V and Beroukas D et al (2007). Characterisation of a dendritic cell subset in synovial tissue, which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis. Ann. Rheum Dis., 66: 992- 999.
185. Wandstrat A and Wakeland E (2001). The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat. Immunol., 2: 802-809.
186. Wang LL, Worley K, Gannavarapu A, Chintagumpala MM, Levy ML and Plon SE (2002). Intron-Size constraint as a mutational mechanism in rothmund- Thomson Syndrome. The American Journal of Human Genetics, 71: 165.
187. Wang XB, Giscombe R, Yan Z, Heiden T, Xu D and Lefvert AK (2002). Expression of CTLA-4 by human monocytes. Scand J. Immunol., 55: 53-60.
188. Wang XB, Zheng CY, Giscombe R and Lefvert AK (2001). Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Scand J Immunol., 54: 453-458.
189. Watford WT, Hissong BD, Bream JH, Kamnno Y, Muul L and O'Shea JJ (2004). Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT 4. Immunol. Rev., 202: 139-156.
190. Yan Z, Ferucci ED and Geraghty DE et al (2007). Resequencing of the human major his to compatibility complex in patients with rheumatoid arthritis and healthy controls in Alaska Natives of Southeast Alaska. Tissue Antigens, 70: 487-494.
191. Yang HC, Liang YJ, Chung CM, Chen JW and Pan WH (2009). Genome-wide gene-based association study. BMC. Proc., 3(7): S135.
192. Zervou MI, Sidiropoulos P, Petraki E, Vazgiourakis V, Krasoudaki E, Raptopoulou A, Kritikos H, Choustoulaki E, Boumpas DT and Goulielmos GN (2008). Association of a TRAF 1 and a STAT 4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum. Immunol., 69: 567-571.
193. Zuk O, Hechter E, Sunyaev SR and Lander ES (2012). The mystery of missing heritability: Genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA, 109(4): 1193-1198.